MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1281 to 1300 of 166,322 approvalsPage 65 of 8317

Salbutamol Sulfate Injection

Approval Number: 国药准字H20253535
Registration: Mar 4, 2025
华夏生生药业（北京）有限公司

Macrogol 4000 Powder

Approval Number: 国药准字H20253498
Registration: Mar 4, 2025
山西千汇药业有限公司

Avatrombopag Maleate tablet

Approval Number: 国药准字H20253526
Registration: Mar 4, 2025
浙江诺得药业有限公司

Furosemide Oral Solution

Approval Number: 国药准字H20253554
Registration: Mar 4, 2025
仁合益康集团有限公司

Hemofiltration Replacement Fluid of Sodium Citrate

Approval Number: 国药准字H20253505
Registration: Mar 4, 2025
成都青山利康药业股份有限公司

Naloxone Hydrochloride Injection

Approval Number: 国药准字H20253488
Registration: Mar 4, 2025
海南灵康制药有限公司

Methocarbamol Injection

Approval Number: 国药准字H20253529
Registration: Mar 4, 2025
杭州端本医药科技有限公司

Acetylcysteine Solution for Inhalation

Approval Number: 国药准字H20253503
Registration: Mar 4, 2025
山西德元堂药业有限公司

Roxadustat Capsules

Approval Number: 国药准字H20253545
Registration: Mar 4, 2025
浙江尖峰药业有限公司

Voriconazole for Oral Suspension

Approval Number: 国药准字HJ20250023
Registration: Mar 4, 2025
HETERO LABS LIMITED

Furosemide Injection

Approval Number: 国药准字H20253555
Registration: Mar 4, 2025
云南药科院生物医药股份有限公司

Nicorandil for Injection

Approval Number: 国药准字H20253492
Registration: Mar 4, 2025
北京沃邦医药科技有限公司

Elranatamab Injection

Approval Number: 国药准字SJ20250011
Registration: Mar 4, 2025
PFIZER INC.

Nicorandil for Injection

Approval Number: 国药准字H20253490
Registration: Mar 4, 2025
重庆莱美药业股份有限公司

Procaterol Hydrochloride Inhalation Solution

Approval Number: 国药准字H20253558
Registration: Mar 4, 2025
仁合益康集团有限公司

Adenosine Injection

Approval Number: 国药准字H20253495
Registration: Mar 4, 2025
遂成药业股份有限公司

Loxoprofen Sodium Cataplasms

Approval Number: 国药准字H20253493
Registration: Mar 4, 2025
湖南普道医药技术有限公司

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20253482
Registration: Mar 4, 2025
浙江永太药业有限公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.